New equity research report: Sopharma’s recovery is speeding up

Sopharma, the leading generic pharmaceutical company in Bulgaria, is recovering faster than expected from the Russia/Ukraine conflict on strong exports – this was concluded in the latest equity research report by ELANA Trading analysts covering Q1 2017 earnings of Sopharma. Sopharma’s top line recovery speeding up Sopharma’s top line is recovering faster than ELANA Trading’s… Read more

Ognyan Donev, CEO Sopharma

CEO Ognyan Donev ups his stake in Sopharma

CEO Ognyan Donev controlled key shareholder in Sopharma (3JR BU) ups his stake in the company, according to a regulatory filing. Donev Investments Holding has acquired 503 000 shares or 0.37% of the share capital, according to the filing. Post the transaction Donev Investments Holding’s stake has increased to 25.15%. Sopharma’s key holding structure acquires… Read more